当前位置： SCI文献检索 > Applied Health Economics and Health Policy期刊下所有文献 > Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision making.

Why does economic analysis in health care not get implemented more? Towards a greater understanding of the rules of the game and the costs of decision making.

Abstract：

:Despite recent initiatives across a number of countries to institutionalise the use of economic evaluation in the assessment of new technologies, the evidence suggests that, to date, the impact of economic analysis on health sector decision making in practice has been low. This paper proposes that incentive compatibility problems associated with much of the decision making that economics is meant to inform is a major factor in this. The argument involves recognition that economic priority setting tends to create winners and losers and, as a consequence, any change in the status quo will tend to impose direct costs on those decision makers required to implement them. At the same time, such individuals often lack any stake over the benefits of such decisions. In this type of institutional setting, the prospects of achieving the necessary cooperation for implementation are likely to be low, particularly if it is viewed as being part of a 'one-off' initiative. Conventional health economic analysis and agency theory are limited in the extent to which they can address this problem. Such forms of analyses tend to lack an appreciation of broader institutional characteristics, including the prevailing values and norms within a decision making context that are potentially important in promoting cooperation and thus the prospects of implementation.

journal_name

Appl Health Econ Health Policy

journal_title

Applied health economics and health policy

authors

Jan S

subject

Has Abstract

pub_date

2003-01-01 00:00:00

pages

17-24

issue

1

eissn

1175-5652

issn

1179-1896

journal_volume

2

pub_type

杂志文章,评审

相关文献

Applied Health Economics and Health Policy文献大全
  • Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model.

    abstract：BACKGROUND:European guidelines advocate the measurement of on-treatment hepatitis C virus (HCV) RNA in order to determine optimal therapy duration (response-guided therapy [RGT]) in patients with rapid virological response (RVR) or delayed virological response (DVR). Treatment response is highly dependent upon the exte...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-012-0002-0

    authors： McEwan P,Kim R,Yuan Y

    更新日期：2013-02-01 00:00:00

  • Cost and Budget Impact Analysis of an Accurate Intraoperative Sentinel Lymph Node Diagnosis for Breast Cancer Metastasis.

    abstract：BACKGROUND:Conventional intraoperative sentinel lymph node biopsy (SLNB) in breast cancer (BC) has limitations in establishing a definitive diagnosis of metastasis intraoperatively, leading to an unnecessary second operation. The one-step nucleic amplification assay (OSNA) provides accurate intraoperative diagnosis and...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0235-4

    authors： Saruta Y,Puig-Junoy J

    更新日期：2016-06-01 00:00:00

  • The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010.

    abstract：BACKGROUND:In Slovenia during the period 2000-2010, the number of years of potential life lost before the age of 70 years per 100,000 population under 70 years of age declined 25 %. OBJECTIVE:The aim of this study was to test the hypothesis that pharmaceutical innovation played a key role in reducing premature mortali...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-014-0144-3

    authors： Lichtenberg FR

    更新日期：2015-04-01 00:00:00

  • Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States.

    abstract：BACKGROUND:Liposomal amphotericin B (L-AMB) and amphotericin B lipid complex (ABLC) are both indicated for treating invasive fungal infections (IFIs) caused by Aspergillus, Candida and Cryptococcus spp. among patients who are refractory to or intolerant of conventional amphotericin B (CAB). Prior studies have suggested...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-013-0072-7

    authors： Yang H,Chaudhari P,Zhou ZY,Wu EQ,Patel C,Horn DL

    更新日期：2014-02-01 00:00:00

  • Stated Uptake of Physical Activity Rewards Programmes Among Active and Insufficiently Active Full-Time Employees.

    abstract：BACKGROUND:Employers are increasingly relying on rewards programmes in an effort to promote greater levels of activity among employees; however, if enrolment in these programmes is dominated by active employees, then they are unlikely to be a good use of resources. OBJECTIVE:This study uses a stated-preference survey ...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-017-0327-9

    authors： Ozdemir S,Bilger M,Finkelstein EA

    更新日期：2017-10-01 00:00:00

  • The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations.

    abstract：BACKGROUND:Immunization rates for human papillomavirus (HPV) infections remain low among teenagers despite strong evidence of the effectiveness of vaccines. Physician recommendations of the vaccine are far from universal. Several states have enacted policies that mandate HPV vaccination or distribute educational materi...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0225-6

    authors： Moghtaderi A,Adams S

    更新日期：2016-06-01 00:00:00

  • Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.

    abstract：BACKGROUND:Response to growth hormone (GH) therapy may vary between individual patients. Therefore the use of GH in children should be closely monitored to avoid over, under, or ineffective treatment regimens. The treatment response can be evaluated using growth prediction models. In an effort to improve the accuracy o...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-013-0030-4

    authors： Kaspers S,Ranke MB,Han D,Loftus J,Wollmann H,Lindberg A,Roelants M,Kleintjens J

    更新日期：2013-06-01 00:00:00

  • The impact of inclusion criteria in health economic assessments.

    abstract：:The debate surrounding whether the findings of efficacy studies are applicable to real-world treatment situations is ongoing. The issue of lack of applicability due to a lack of clinical heterogeneity could be addressed by employing less restrictive inclusion criteria. Given that health economic assessments based on c...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11590150-000000000-00000

    authors： Richter A,Thieda P,Thaler K,Gartlehner G

    更新日期：2011-05-01 00:00:00

  • Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.

    abstract：BACKGROUND:Cervical cancer ranks fourth amongst the commonest malignancies worldwide and the second most prevalent cancer afflicting women in low-to-middle income countries (LMICs), hence, of great public health importance. LMICs are the most affected regions as evidenced by their high prevalence of the disease. Mortal...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-020-00576-7

    authors： Okeah BO,Ridyard CH

    更新日期：2020-10-01 00:00:00

  • Cost of Medicare for All: Review of the Estimates.

    abstract：:This paper critically evaluates the estimates of the cost of Medicare for All (M4A) in the USA. Six studies that estimate the 1-year total cost of M4A in the USA are reviewed. These studies find that M4A would increase national health spending by as much as 16.9% or decrease it by 20.0%, representing a range of estima...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-021-00636-6

    authors： Nyman JA

    更新日期：2021-01-25 00:00:00

  • Economic Evaluations of Guideline-Based Care for Chronic Wounds: a Systematic Review.

    abstract：OBJECTIVES:The aim of this study was to review all published economic evaluations of guideline-based care for chronic wounds and to assess how useful these studies are for decision making in health services. METHODS:Embase, PubMed, Scopus, Health Technology Assessment (HTA) and National Health Service Economic Evaluat...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-018-0403-9

    authors： Cheng Q,Graves N,Pacella RE

    更新日期：2018-10-01 00:00:00

  • Demand for outpatient healthcare: empirical findings from rural India.

    abstract：BACKGROUND:Price, income and health status are likely to affect the demand for healthcare in developing countries, and their quantitative effects are unclear in the literature. Some studies report that prices are not important determinants, while others conclude that prices are important determinants of the demand for ...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/BF03256160

    authors： Sarma S

    更新日期：2009-01-01 00:00:00

  • Triangulating health expenditure estimates from different data sources in developing countries: the case of Pakistan's private health expenditure.

    abstract：:This article deals with the accuracy of statistical records used for political decision making and international comparative analysis. In developing countries, even major macroeconomic indicators can include data inadequacies and methodological differences in data generation between statistical agencies. Existing data...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11595230-000000000-00000

    authors： Lorenz C

    更新日期：2012-01-01 00:00:00

  • Genetic health technology and economic evaluation: a critical review.

    abstract：:The aim of the review is to establish whether, on the basis of previous published evidence, current accepted guidance for health economic evaluation needs to be adapted to evaluate healthcare based on use of genetic information. Online literature search strategies were designed (using PubMed and the NHS Economic Evalu...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.2165/00148365-200605010-00004

    authors： Jarrett J,Mugford M

    更新日期：2006-01-01 00:00:00

  • The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience.

    abstract：BACKGROUND:There are limited economic evaluations comparing coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) for multi-vessel coronary artery disease (MVCAD) in contemporary, routine clinical practice. OBJECTIVE:The aim was to perform a cost-effectiveness analysis comparing CABG and ...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-018-0407-5

    authors： Ariyaratne TV,Ademi Z,Huq M,Rosenfeldt F,Duffy SJ,Parkinson B,Yap CH,Smith J,Billah B,Yan BP,Brennan AL,Tran L,Reid CM

    更新日期：2018-10-01 00:00:00

  • Implementing Guidelines: The Cost and Clinical Impact of Anticoagulants in the UK Atrial Fibrillation Population.

    abstract：BACKGROUND:Updated treatment guidelines for atrial fibrillation (AF) have been released by the National Institute for Health and Care Excellence (NICE) in the UK, and highlight a current shortfall in the prescription of anticoagulants to patients with AF for stroke prevention. OBJECTIVE:To design a budget impact model...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-015-0180-7

    authors： Shields GE,Bates AE,Chapman AM

    更新日期：2015-10-01 00:00:00

  • A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators.

    abstract：:This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined with a quantitative an...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-014-0150-5

    authors： Hu S,Zhang Y,He J,Du L,Xu M,Xie C,Peng Y,Wang L

    更新日期：2015-08-01 00:00:00

  • Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.

    abstract：BACKGROUND:Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease. OBJECTIVE:To estimate the cost effectivene...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11535520-000000000-00000

    authors： Logman JF,Heeg BM,Herlitz J,van Hout BA

    更新日期：2010-01-01 00:00:00

  • Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.

    abstract：:The rapid rise in pharmaceutical costs in France has been driven by new technologies and the growing prevalence of chronic diseases as well as considerable prescribing freedom and choice of physician among patients. This has led to the introduction of a number of reforms and initiatives in an attempt to moderate expen...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/BF03256162

    authors： Sermet C,Andrieu V,Godman B,Van Ganse E,Haycox A,Reynier JP

    更新日期：2010-01-01 00:00:00

  • Supplier-induced demand: reconsidering the theories and new Australian evidence.

    abstract：:This paper reconsiders the evidence and several of the key arguments associated with the theory of supplier-induced demand (SID). It proposes a new theory to explain how ethical behaviour is consistent with SID. The purpose of a theory of demand and one criterion for the evaluation of a theory is the provision of a pl...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.2165/00148365-200605020-00003

    authors： Richardson JR,Peacock SJ

    更新日期：2006-01-01 00:00:00

  • New anti-rebate legislation in South Korea.

    abstract：:The South Korean Government recently announced a reform in the drug anti-rebate law, with the purpose of eradicating pervasive, unethical, and illegal rebate practices in pharmaceutical marketing. The main objective of this reform is to have the ability to bring criminal charges against doctors and pharmacists for rec...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/s40258-013-0029-x

    authors： Yu SY,Yang BM,Kim JH

    更新日期：2013-08-01 00:00:00

  • Measuring Efficiency of Health Systems of the Middle East and North Africa (MENA) Region Using Stochastic Frontier Analysis.

    abstract：OBJECTIVE:The main purpose of this study is to measure the technical efficiency of twenty health systems in the Middle East and North Africa (MENA) region to inform evidence-based health policy decisions. In addition, the effects of alternative stochastic frontier model specification on the empirical results are examin...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0230-9

    authors： Hamidi S,Akinci F

    更新日期：2016-06-01 00:00:00

  • Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.

    abstract：BACKGROUND:Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is known about the economic burden associated with PAH patients in the US. OBJECTIVES:The objective of this study was to estimate excess direct costs associated with privately insured PAH patients in the US. METHODS:From a privately ...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11592430-000000000-00000

    authors： Kirson NY,Birnbaum HG,Ivanova JI,Waldman T,Joish V,Williamson T

    更新日期：2011-09-01 00:00:00

  • Germany's decision rule for setting ceiling prices of drugs: a comparative analysis with other decision rules.

    abstract：:In Germany, the Institute for Quality and Efficiency in Health Care (IQWiG) makes recommendations for ceiling prices of drugs based on an evaluation of the relationship between costs and effectiveness. To set ceiling prices, IQWiG uses the following decision rule: the incremental cost-effectiveness ratio (ICER) of a n...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.2165/11586640-000000000-00000

    authors： Gandjour A

    更新日期：2011-03-01 00:00:00

  • Mental health: A Particular Challenge Confronting Policy Makers and Economists.

    abstract：:The first objective of this paper is to expound the particular challenge posed by the occurrence of inconsistency in the expression of preferences by mental health patients to both economists and policy makers. Since this difficulty cannot be resolved, the second aim of the paper is to identify agents who may be count...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-019-00479-2

    authors： Zweifel P

    更新日期：2020-04-01 00:00:00

  • Inclusion of compliance and persistence in economic models: past, present and future.

    abstract：:Economic models are developed to provide decision makers with information related to the real-world effectiveness of therapeutics, screening and diagnostic regimens. Although compliance with these regimens often has a significant impact on real-world clinical outcomes and costs, compliance and persistence have histori...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章,评审

    doi：10.1007/BF03261872

    authors： Kadambi A,Leipold RJ,Kansal AR,Sorensen S,Getsios D

    更新日期：2012-11-01 00:00:00

  • Does Insurance Status Influence a Patient's Hospital Charge?

    abstract：BACKGROUND:There is obscurity regarding how US hospitals determine patients' charges. Whether insurance status influences a patient's hospital charge has not been explored. OBJECTIVE:The objective of this study was to determine whether hospitals charge patients differently based on their insurance status. METHODS:Thi...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-017-0308-z

    authors： Woodworth L,Romano PS,Holmes JF

    更新日期：2017-06-01 00:00:00

  • Evaluating the Cost Effectiveness of a Suicide Prevention Campaign Implemented in Ontario, Canada.

    abstract：BACKGROUND:Although suicide-prevention campaigns have been implemented in numerous countries, Canada has yet to implement a strategy nationally. This is the first study to examine the cost utility of the implementation of a multidimensional suicide-prevention program that combines several interventions over a 50-year t...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-019-00511-5

    authors： Lebenbaum M,Cheng J,de Oliveira C,Kurdyak P,Zaheer J,Hancock-Howard R,Coyte PC

    更新日期：2020-04-01 00:00:00

  • Household Size and the Decision to Purchase Health Insurance in Cambodia: Results of a Discrete-Choice Experiment with Scale Adjustment.

    abstract：BACKGROUND:Community-based health insurance (CBHI) schemes have been introduced in low- and middle-income countries to increase health service utilization and provide financial protection from high healthcare expenditures. OBJECTIVE:We assess the impact of household size on decisions to enroll in CBHI and demonstrate ...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：10.1007/s40258-016-0222-9

    authors： Ozawa S,Grewal S,Bridges JF

    更新日期：2016-04-01 00:00:00

  • The influence of bonus payments to doctors on hospital revenue: results of a quasi-experimental study.

    abstract：:There is wide consensus that the ways in which providers are reimbursed by third parties will affect their behaviour and, hence, the efficient use of limited resources and the performance of health systems. However, there seems to be little evidence on how payment to hospital-based doctors affects hospital performance...

    journal_title：Applied health economics and health policy

    pub_type： 杂志文章

    doi：

    authors： Liu X,Mills A

    更新日期：2003-01-01 00:00:00